Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 4 (2007), Issue 2 (February)

1. Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study.
   Lancet Oncol, 8(2): 111-8. [Abstract] [Full-text]
2. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.
   Oncogene, 26(5): 765-73. [Abstract] [Full-text]
3. Small cell cancer of the pleura, kidney, and thymus.
   Semin Oncol, 34(1): 67-9. [Abstract] [Full-text]
4. Small cell carcinoma of the breast.
   Semin Oncol, 34(1): 64-6. [Abstract] [Full-text]
5. Small cell carcinoma of the female genital tract.
   Semin Oncol, 34(1): 57-63. [Abstract] [Full-text]
6. Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach.
   Semin Oncol, 34(1): 43-50. [Abstract] [Full-text]
7. Small cell carcinoma of unknown primary.
   Semin Oncol, 34(1): 39-42. [Abstract] [Full-text]
8. The pathology of extrapulmonary small cell carcinoma.
   Semin Oncol, 34(1): 30-8. [Abstract] [Full-text]
9. Unusual and underappreciated: small cell carcinoma of the prostate.
   Semin Oncol, 34(1): 22-9. [Abstract] [Full-text]
10. Extrapulmonary small cell carcinoma of the bladder.
    Semin Oncol, 34(1): 15-21. [Abstract] [Full-text]
11. Small cell carcinoma of the head and neck: a review.
    Semin Oncol, 34(1): 3-14. [Abstract] [Full-text]
12. Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis.
    Cancer Sci, 98(3): 315-20. [Abstract] [Full-text]
13. Exchanging human Fcgamma1 with murine Fcgamma2a highly potentiates anti-tumor activity of anti-EpCAM antibody adecatumumab in a syngeneic mouse lung metastasis model.
    Cancer Immunol Immunother, 56(4): 459-68. [Abstract] [Full-text]
14. Nonsteroidal anti-inflammatory drugs and risk of lung cancer.
    Int J Cancer, 120(7): 1565-72. [Abstract] [Full-text]
15. Inhibition of lung carcinogenesis by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in the A/J mouse model: evidence of retinoid mitigation of vitamin D toxicity.
    Int J Cancer, 120(7): 1402-9. [Abstract] [Full-text]
16. Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts. Evidence linking EGFR signaling to gefitinib antitumor response.
    Int J Cancer, 120(7): 1579-90. [Abstract] [Full-text]
17. Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.
    Cancer Res, 67(3): 1176-83. [Abstract] [Full-text]
18. p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer.
    Cancer Res, 67(3): 1163-9. [Abstract] [Full-text]
19. Antiadhesive effects of GRN163L--an oligonucleotide N3'->P5' thio-phosphoramidate targeting telomerase.
    Cancer Res, 67(3): 1121-9. [Abstract] [Full-text]
20. Population screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literature.
    Thorax, 62(2): 131-8. [Abstract] [Full-text]
21. Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts.
    Thorax, 62(2): 126-30. [Abstract] [Full-text]
22. Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component.
    Cancer, 109(4): 741-50. [Abstract] [Full-text]
23. Sequential chemotherapy in nonsmall-cell lung cancer: cisplatin and gemcitabine followed by docetaxel.
    Cancer, 109(4): 727-31. [Abstract] [Full-text]
24. A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials.
    Cancer, 109(4): 787-95. [Abstract] [Full-text]
25. Randomized phase II trial of two different schedules of docetaxel plus cisplatin as first-line therapy in advanced nonsmall cell lung cancer.
    Cancer, 109(4): 732-40. [Abstract] [Full-text]
26. Pulmonary cavitary mass containing a mural nodule: differential diagnosis between intracavitary aspergilloma and cavitating lung cancer on contrast-enhanced computed tomography.
    Clin Radiol, 62(3): 227-32. [Abstract] [Full-text]
27. Possible effects on smokers of cigarette mentholation: a review of the evidence relating to key research questions.
    Regul Toxicol Pharmacol, 47(2): 189-203. [Abstract] [Full-text]
28. Diversity of the angiogenic phenotype in non-small cell lung cancer.
    Am J Respir Cell Mol Biol, 36(3): 343-50. [Abstract] [Full-text]
29. Plasmacytoid dendritic cells from human lung cancer draining lymph nodes induce Tc1 responses.
    Am J Respir Cell Mol Biol, 36(3): 360-7. [Abstract] [Full-text]
30. Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects.
    Cancer Gene Ther, 14(3): 316-26. [Abstract] [Full-text]
31. Electrogene therapy using endostatin, with or without suicide gene therapy, suppresses murine mammary tumor growth and metastasis.
    Cancer Gene Ther, 14(3): 268-78. [Abstract] [Full-text]
32. Frequent requirement of hedgehog signaling in non-small cell lung carcinoma.
    Oncogene, 26(7): 1046-55. [Abstract] [Full-text]
33. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model.
    Cancer Res, 67(4): 1744-9. [Abstract] [Full-text]
34. Intrapulmonary teratoma: an exceptional disease.
    Ann Thorac Surg, 83(3): 1194-6. [Abstract] [Full-text]
35. Single-stage surgical treatment of synchronous bilateral multiple lung cancers.
    Ann Thorac Surg, 83(3): 1146-51. [Abstract] [Full-text]
36. Predicted versus observed FEV1 and DLCO after major lung resection: a prospective evaluation at different postoperative periods.
    Ann Thorac Surg, 83(3): 1134-9. [Abstract] [Full-text]
37. A new catheter technique for thoracic subarachnoid neurolysis in advanced lung cancer patients.
    Pain Pract, 7(1): 27-30. [Abstract] [Full-text]
38. Benzo[a]pyrene-7,8-dihydrodiol promotes checkpoint activation and G2/M arrest in human bronchoalveolar carcinoma H358 cells.
    Mol Pharmacol, 71(3): 744-50. [Abstract] [Full-text]
39. Modified HPV16 E7/HSP70 DNA vaccine with high safety and enhanced cellular immunity represses murine lung metastatic tumors with downregulated expression of MHC class I molecules.
    Gynecol Oncol, 104(3): 564-71. [Abstract] [Full-text]
40. Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.
    Cancer Chemother Pharmacol, 59(5): 621-9. [Abstract] [Full-text]
41. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
    Cancer Chemother Pharmacol, 59(5): 575-80. [Abstract] [Full-text]
42. Cytology of desmoplastic small round-cell tumor: comparison of pre- and post-chemotherapy fine-needle aspiration biopsies.
    Cancer, 111(1): 41-6. [Abstract] [Full-text]
43. DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.
    N Engl J Med, 356(8): 800-8. [Abstract] [Full-text]
44. Lung cancer risk and workplace exposure to environmental tobacco smoke.
    Am J Public Health, 97(3): 545-51. [Abstract] [Full-text]
45. Lung cancers attributable to environmental tobacco smoke and air pollution in non-smokers in different European countries: a prospective study.
    Environ Health, 6: 7. [Abstract] [Full-text]
46. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma.
    Pathol Int, 57(4): 190-9. [Abstract] [Full-text]
47. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
    Pathol Int, 57(4): 171-7. [Abstract] [Full-text]
48. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Cancer Genet Cytogenet, 173(2): 107-13. [Abstract] [Full-text]
49. Sentinel node navigation segmentectomy for clinical stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg, 133(3): 780-5. [Abstract] [Full-text]
50. Video-assisted thoracic surgery does not reduce the incidence of postoperative atrial fibrillation after pulmonary lobectomy.
    J Thorac Cardiovasc Surg, 133(3): 775-9. [Abstract] [Full-text]
51. A novel video-assisted anatomic segmentectomy technique: selective segmental inflation via bronchofiberoptic jet followed by cautery cutting.
    J Thorac Cardiovasc Surg, 133(3): 753-8. [Abstract] [Full-text]
52. Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer.
    J Thorac Cardiovasc Surg, 133(3): 746-52. [Abstract] [Full-text]
53. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases.
    Radiology, 242(3): 882-8. [Abstract] [Full-text]
54. Risk of lung cancer from residential heating and cooking fuels in Montreal, Canada.
    Am J Epidemiol, 165(6): 634-42. [Abstract] [Full-text]
55. Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer.
    J Clin Oncol, 25(7): 760-6. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.